
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Targeting the Tumor Microenvironment of Leukemia and Lymphoma
Uta E. Höpken, Armin Rehm
Trends in cancer (2019) Vol. 5, Iss. 6, pp. 351-364
Closed Access | Times Cited: 84
Uta E. Höpken, Armin Rehm
Trends in cancer (2019) Vol. 5, Iss. 6, pp. 351-364
Closed Access | Times Cited: 84
Showing 26-50 of 84 citing articles:
Drug Resistance: The Role of Exosomal miRNA in the Microenvironment of Hematopoietic Tumors
Mariaconcetta Cariello, Angela Squilla, Martina Piacente, et al.
Molecules (2022) Vol. 28, Iss. 1, pp. 116-116
Open Access | Times Cited: 17
Mariaconcetta Cariello, Angela Squilla, Martina Piacente, et al.
Molecules (2022) Vol. 28, Iss. 1, pp. 116-116
Open Access | Times Cited: 17
Leukemia’s Next Top Model? Syngeneic Models to Advance Adoptive Cellular Therapy
Jaquelyn T. Zoine, Sarah E. Moore, Mireya Paulina Velasquez
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 16
Jaquelyn T. Zoine, Sarah E. Moore, Mireya Paulina Velasquez
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 16
Cytokine profiles in patients with newly diagnosed diffuse large B-cell lymphoma: IL-6 and IL-10 levels are associated with adverse clinical features and poor outcomes
Chenhui Bao, Jiayan Gu, Xin Huang, et al.
Cytokine (2023) Vol. 169, pp. 156289-156289
Open Access | Times Cited: 10
Chenhui Bao, Jiayan Gu, Xin Huang, et al.
Cytokine (2023) Vol. 169, pp. 156289-156289
Open Access | Times Cited: 10
Targeting CD47-SIRPα axis for Hodgkin and non-Hodgkin lymphoma immunotherapy
Pengcheng Zhao, Long-Yan Xie, Lei Yu, et al.
Genes & Diseases (2023) Vol. 11, Iss. 1, pp. 205-217
Open Access | Times Cited: 9
Pengcheng Zhao, Long-Yan Xie, Lei Yu, et al.
Genes & Diseases (2023) Vol. 11, Iss. 1, pp. 205-217
Open Access | Times Cited: 9
High expression of B7-H3 on monocyte/macrophages in tumor microenvironment promotes lung cancer progression by inhibiting apoptosis
Dongze Zhang, Haitao Huang, Xin Gao, et al.
Translational Oncology (2024) Vol. 41, pp. 101874-101874
Open Access | Times Cited: 3
Dongze Zhang, Haitao Huang, Xin Gao, et al.
Translational Oncology (2024) Vol. 41, pp. 101874-101874
Open Access | Times Cited: 3
Decoding leukemia at the single-cell level: clonal architecture, classification, microenvironment, and drug resistance
J Liu, Penglei Jiang, Zezhen Lu, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 3
J Liu, Penglei Jiang, Zezhen Lu, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 3
TYK2 in Tumor Immunosurveillance
Anzhelika Karjalainen, Stephen Shoebridge, Milica Krunic, et al.
Cancers (2020) Vol. 12, Iss. 1, pp. 150-150
Open Access | Times Cited: 26
Anzhelika Karjalainen, Stephen Shoebridge, Milica Krunic, et al.
Cancers (2020) Vol. 12, Iss. 1, pp. 150-150
Open Access | Times Cited: 26
Epigenetic alterations and advancement of lymphoma treatment
Shuhui Zhuang, Zhaobo Yang, Zhuangzhuang Cui, et al.
Annals of Hematology (2023) Vol. 103, Iss. 5, pp. 1435-1454
Closed Access | Times Cited: 8
Shuhui Zhuang, Zhaobo Yang, Zhuangzhuang Cui, et al.
Annals of Hematology (2023) Vol. 103, Iss. 5, pp. 1435-1454
Closed Access | Times Cited: 8
The Hepatic Microenvironment Uniquely Protects Leukemia Cells through Induction of Growth and Survival Pathways Mediated by LIPG
Haobin Ye, Mohammad Minhajuddin, Anna Krug, et al.
Cancer Discovery (2020) Vol. 11, Iss. 2, pp. 500-519
Open Access | Times Cited: 21
Haobin Ye, Mohammad Minhajuddin, Anna Krug, et al.
Cancer Discovery (2020) Vol. 11, Iss. 2, pp. 500-519
Open Access | Times Cited: 21
Identification and Validation of a Prognostic Gene Signature for Diffuse Large B-Cell Lymphoma Based on Tumor Microenvironment-Related Genes
Tao Pan, Yizi He, Huan Chen, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 18
Tao Pan, Yizi He, Huan Chen, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 18
Endothelial cell–leukemia interactions remodel drug responses, uncovering T-ALL vulnerabilities
Luca Vincenzo Cappelli, Danilo Fiore, Jude M. Phillip, et al.
Blood (2022) Vol. 141, Iss. 5, pp. 503-518
Open Access | Times Cited: 13
Luca Vincenzo Cappelli, Danilo Fiore, Jude M. Phillip, et al.
Blood (2022) Vol. 141, Iss. 5, pp. 503-518
Open Access | Times Cited: 13
Reshaping the tumor microenvironment: The versatility of immunomodulatory drugs in B-cell neoplasms
Hao Guo, Jingyi Yang, Haoran Wang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 13
Hao Guo, Jingyi Yang, Haoran Wang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 13
Cancer-associated fibroblasts in hematologic malignancies: elucidating roles and spotlighting therapeutic targets
Ziyang Ding, Run Shi, Weikang Hu, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 7
Ziyang Ding, Run Shi, Weikang Hu, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 7
Enhanced tumor immunotherapy by polyfunctional CD19-CAR T cells engineered to secrete anti-CD47 single-chain variable fragment
Yingqi Qiu, Peiyun Liao, Hao Wang, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 15, pp. 4948-4966
Open Access | Times Cited: 7
Yingqi Qiu, Peiyun Liao, Hao Wang, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 15, pp. 4948-4966
Open Access | Times Cited: 7
Development of Epigenetic Modifiers with Therapeutic Potential in FMS-Related Tyrosine Kinase 3/Internal Tandem Duplication (FLT3/ITD) Acute Myeloid Leukemia and Other Blood Malignancies
Gabriele Carullo, Sara Rossi, Valentina Giudice, et al.
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 7, pp. 2125-2142
Closed Access | Times Cited: 2
Gabriele Carullo, Sara Rossi, Valentina Giudice, et al.
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 7, pp. 2125-2142
Closed Access | Times Cited: 2
<p>Esophageal Microenvironment: From Precursor Microenvironment to Premetastatic Niche</p>
Peng Han, Peng Cao, Shan Hu, et al.
Cancer Management and Research (2020) Vol. Volume 12, pp. 5857-5879
Open Access | Times Cited: 19
Peng Han, Peng Cao, Shan Hu, et al.
Cancer Management and Research (2020) Vol. Volume 12, pp. 5857-5879
Open Access | Times Cited: 19
A 9-LncRNA Signature for Predicting Prognosis and Immune Response in Diffuse Large B-Cell Lymphoma
Xiaoxuan Wang, Yaxiao Lu, Ziyi Liu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 12
Xiaoxuan Wang, Yaxiao Lu, Ziyi Liu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 12
Prediction of prognosis and immunotherapy response of amino acid metabolism genes in acute myeloid leukemia
Hui Zhou, Fengjuan Wang, Ting Niu
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 11
Hui Zhou, Fengjuan Wang, Ting Niu
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 11
EBV dUTPase: A Novel Modulator of Inflammation and the Tumor Microenvironment in EBV-Associated Malignancies
Marshall V. Williams, Irene Mena-Palomo, Brandon Cox, et al.
Cancers (2023) Vol. 15, Iss. 3, pp. 855-855
Open Access | Times Cited: 6
Marshall V. Williams, Irene Mena-Palomo, Brandon Cox, et al.
Cancers (2023) Vol. 15, Iss. 3, pp. 855-855
Open Access | Times Cited: 6
Emerging Therapeutic Targets and Drug Resistance Mechanisms in Immunotherapy of Hematological Malignancies
Wioletta Olejarz, Grzegorz Basak
Cancers (2023) Vol. 15, Iss. 24, pp. 5765-5765
Open Access | Times Cited: 6
Wioletta Olejarz, Grzegorz Basak
Cancers (2023) Vol. 15, Iss. 24, pp. 5765-5765
Open Access | Times Cited: 6
A prognostic immune risk score for diffuse large B‐cell lymphoma
Shu‐Yun Ma, Xiao‐Peng Tian, Jun Cai, et al.
British Journal of Haematology (2021) Vol. 194, Iss. 1, pp. 111-119
Open Access | Times Cited: 15
Shu‐Yun Ma, Xiao‐Peng Tian, Jun Cai, et al.
British Journal of Haematology (2021) Vol. 194, Iss. 1, pp. 111-119
Open Access | Times Cited: 15
Graphdiyne oxide nanosheets exert anti-lymphoma effect by killing cancer stem cells and remodeling tumor microenvironment
Jinxin Li, Qiwei Wang, Huan Lu, et al.
Nano Today (2022) Vol. 46, pp. 101622-101622
Closed Access | Times Cited: 10
Jinxin Li, Qiwei Wang, Huan Lu, et al.
Nano Today (2022) Vol. 46, pp. 101622-101622
Closed Access | Times Cited: 10
Monocytic MDSC as a source of immunosuppressive cytokines in chronic lymphocytic leukemia (CLL) microenvironment
Wioleta Kowalska, Agnieszka Bojarska‐Junak
Folia Histochemica et Cytobiologica (2020) Vol. 58, Iss. 1, pp. 25-36
Open Access | Times Cited: 15
Wioleta Kowalska, Agnieszka Bojarska‐Junak
Folia Histochemica et Cytobiologica (2020) Vol. 58, Iss. 1, pp. 25-36
Open Access | Times Cited: 15
A seven-nuclear receptor-based prognostic signature in breast cancer
Feng Wu, W. Chen, Xiaoning Kang, et al.
Clinical & Translational Oncology (2020) Vol. 23, Iss. 7, pp. 1292-1303
Closed Access | Times Cited: 15
Feng Wu, W. Chen, Xiaoning Kang, et al.
Clinical & Translational Oncology (2020) Vol. 23, Iss. 7, pp. 1292-1303
Closed Access | Times Cited: 15
Amino acid metabolism: challenges and opportunities for the therapeutic treatment of leukemia and lymphoma
Peiyun Liao, Ning Chang, Binyan Xu, et al.
Immunology and Cell Biology (2022) Vol. 100, Iss. 7, pp. 507-528
Open Access | Times Cited: 9
Peiyun Liao, Ning Chang, Binyan Xu, et al.
Immunology and Cell Biology (2022) Vol. 100, Iss. 7, pp. 507-528
Open Access | Times Cited: 9